PHASE-II TRIAL OF M-AMSA THERAPY IN REFRACTORY HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA - CANCER AND LEUKEMIA GROUP-B STUDY 7972

被引：0
|
作者：
RYBAK, ME
ANDERSON, JR
POULIN, RF
AMREIN, PC
CANELLOS, GP
GOTTLIEB, AJ
机构：
[1] HARVARD UNIV, SCH PUBL HLTH, BOSTON, MA 02115 USA
[2] SUNY UPSTATE MED CTR, SYRACUSE, NY 13210 USA
[3] MASSACHUSETTS GEN HOSP, BOSTON, MA 02114 USA
[4] HARVARD UNIV, SCH MED, DANA FARBER CANC INST, BOSTON, MA 02115 USA
来源：
CANCER TREATMENT REPORTS | 1986年 / 70卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1233 / 1234
页数：2
相关论文
共 50 条
  • [21] THE SUPERIORITY OF CCNU IN THE TREATMENT OF ADVANCED HODGKINS-DISEASE - CANCER AND LEUKEMIA GROUP-B STUDY
    HANSEN, HH
    SELAWRY, OS
    PAJAK, TF
    SPURR, CL
    FALKSON, G
    BRUNNER, K
    CUTTNER, J
    NISSEN, NI
    HOLLAND, JF
    CANCER, 1981, 47 (01) : 14 - 18
  • [22] PHASE-II STUDY OF VINDESINE IN PATIENTS WITH HODGKINS-DISEASE, LYMPHOMA, AND BREAST-CANCER
    GADELMAWLA, N
    HAMZA, MR
    ELSERAFI, M
    ELKHOUDARY, A
    ABOULEINEIN, M
    ELDEMERDASH, S
    CANCER TREATMENT REPORTS, 1983, 67 (03): : 316 - 317
  • [23] PHASE-II TRIAL OF HIGH-DOSE INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA
    MARGOLIN, KA
    ARONSON, FR
    SZNOL, M
    ATKINS, MB
    CIOBANU, N
    FISHER, RI
    WEISS, GR
    DOROSHOW, JH
    BAR, MH
    HAWKINS, MJ
    MIER, JW
    PAIETTA, E
    GAYNOR, EP
    BOLDT, DH
    JOURNAL OF IMMUNOTHERAPY, 1991, 10 (03): : 214 - 220
  • [24] PHASE-II STUDY OF CHEMOTHERAPY OF NON-HODGKINS-LYMPHOMA ARISING IN THE CNS OR EYE
    WHITCUP, SM
    OPHTHALMOLOGY, 1995, 102 (10) : 1572 - 1572
  • [25] A PHASE-II TRIAL OF PEG-L-ASPARAGINASE IN THE TREATMENT OF NON-HODGKINS-LYMPHOMA
    MUSS, HB
    SPELL, N
    SCUDIERY, D
    CAPIZZI, RL
    COOPER, MR
    CRUZ, J
    JACKSON, DV
    RICHARDS, F
    SPURR, CL
    WHITE, DR
    ZEKAN, PJ
    FRANKLIN, A
    INVESTIGATIONAL NEW DRUGS, 1990, 8 (01) : 125 - 130
  • [26] PHASE-II STUDY OF ORAL IDARUBICIN IN FAVORABLE HISTOLOGY NON-HODGKINS-LYMPHOMA
    CASE, DC
    HAYES, DM
    GERBER, M
    GAMS, R
    ERVIN, TJ
    DORSK, BM
    CANCER RESEARCH, 1990, 50 (21) : 6833 - 6835
  • [27] IFOSFAMIDE AND MITOXANTRONE (I-M) IN RELAPSED AND REFRACTORY HIGH-GRADE NON-HODGKINS-LYMPHOMA AND HODGKINS-DISEASE
    DOVEY, GJ
    CHILD, JA
    SIMMONS, AV
    BARNARD, DL
    PARAPIA, L
    MORGAN, M
    FLETCHER, J
    PARKER, D
    NORFOLK, DR
    STONE, J
    STUART, NSA
    TUCKER, J
    HEMATOLOGICAL ONCOLOGY, 1990, 8 (04) : 205 - 213
  • [28] PHASE-II STUDY OF AMSACRINE (M-AMSA) GLUCONATE IN REFRACTORY ADULT ACUTE-LEUKEMIA
    OMURA, GA
    WINTON, EF
    VOGLER, WR
    ZUCKERMAN, KS
    GRILLOLOPEZ, AJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 112 - 112
  • [29] IFOSFAMIDE, EPIRUBICIN AND ETOPOSIDE (IEV) THERAPY IN RELAPSED AND REFRACTORY HIGH-GRADE NON-HODGKINS-LYMPHOMA AND HODGKINS-DISEASE
    ZINZANI, PL
    BARBIERI, E
    VISANI, G
    GHERLINZONI, F
    PERINI, F
    NERI, S
    BENDANDI, M
    AMMENDOLIA, I
    SALVUCCI, M
    BABINI, L
    TURA, S
    HAEMATOLOGICA, 1994, 79 (06) : 508 - 512
  • [30] PHASE-II STUDY OF HEXAMETHYLMELAMINE IN REFRACTORY HODGKINS-DISEASE, OTHER LYMPHOMAS, AND CHRONIC LYMPHOCYTIC-LEUKEMIA
    OMURA, GA
    BROUN, GO
    PAPPS, J
    BIRCH, R
    CANCER TREATMENT REPORTS, 1981, 65 (11-1): : 1027 - 1029
12345